DGX vs TECH · P/E 22, rev $9.87B vs P/E 65, rev $1.22B
Quest Diagnostics Incorporated (DGX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DGX and TECH stock pages for the full models.
Not investment advice.